Document is current
Any future updates will be listed below
-
Authors
Khunti, Kamlesh https://orcid.org/0000-0003-2343-7099
Cheng, Alice Y. Y. https://orcid.org/0000-0003-2729-606X
- License Information
-
More Information
Article History
First Online: 31 May 2023
Competing interests
: K.K. has acted as a consultant, speaker or received grants for investigator-initiated studies for Astra Zeneca, Bayer, Novartis, Novo Nordisk, Sanofi-Aventis, Lilly and Merck Sharp & Dohme, Boehringer Ingelheim, Oramed Pharmaceuticals, Roche and Applied Therapeutics. K.K. is chair of the American Diabetes Association Therapeutic Inertia Initiative. A.Y.Y.C. declares no competing interests.
